RobertMEvansMD
Endocrinology • Jackson, MSDiabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology
Diabetes and Endocrine Clinic of MS
Dr. Evans is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
971 Lakeland Dr
Ste 450
Jackson, MS 39216Phone+1 601-948-5158Fax+1 601-949-6058
Summary
- Dr. Robert Evans is an endocrinologist in Jackson, MS and is affiliated with multiple hospitals in the area, including Mississippi Baptist Medical Center and St. Dominic-Jackson Memorial Hospital. He received his medical degree from University of Mississippi School of Medicine and has been in practice 39 years. He specializes in diabetes, lipid metabolism, and pituitary disorders & neuroendocrinology.
Education & Training
Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1984- Vanderbilt University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1983
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1978 - 1981
University of Mississippi School of MedicineClass of 1978
Certifications & Licensure
MS State Medical License 1978 - 2024
TN State Medical License 1981 - 1984- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 238 citationsThe tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin.Paola Bargagna-Mohan, Adel Hamza, Yang-eon Kim, Yik Khuan Ho, Nirit Mor-Vaknin
Chemistry & Biology. 2007-06-25 - 35 citationsSAFETY AND TOLERABILITY OF LOW DOSE NALTREXONE THERAPY IN CHILDREN WITH MODERATE TO SEVERE CROHN’S DISEASE: A PILOT STUDYJill P. Smith, Douglas Field, Sandra I. Bingaman, Robert M. Evans, David T. Mauger
Journal of Clinical Gastroenterology. 2013-04-01 - 30 citationsInvasive Aspergillosis of the Sphenoid Sinus Manifested as a Pituitary TumorHoward A. Fuchs, Robert M. Evans, Clark R. Gregg
Southern Medical Journal. 1985-11-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
